Johnson & Johnson announced Thursday it has reached an agreement with the Trump administration to reduce prescription drug prices for American patients in exchange for exemptions from pharmaceutical tariffs. The agreement makes J&J the 15th major pharmaceutical company to strike
The United States and the United Kingdom reached a pharmaceutical pricing and trade agreement that raises NICE cost-effectiveness thresholds by 25% and eliminates tariffs on medicine imports between the two countries. The UK committed to increasing NICE’s cost-effectiveness range from
The Trump administration is preparing to launch a new investigation into foreign nations’ drug pricing practices that could pave the way for additional U.S. tariffs on pharmaceutical imports. The probe, expected to be led by the Office of the U.S.
President Donald Trump’s administration has exempted generic drugs from its pharmaceutical tariff policy, according to reports emerging this week. The decision provides significant relief to India’s pharmaceutical industry, which supplies approximately 35% of ingredients used in generic drugs consumed in
The UK government has developed proposals to increase NHS spending on pharmaceuticals by 15-25%, according to multiple reports, as officials attempt to resolve an escalating standoff with the pharmaceutical industry while simultaneously preparing for potential US tariffs under President Trump’s
President Donald Trump has delayed implementing threatened 100% tariffs on branded pharmaceutical products as his administration pursues negotiated drug pricing agreements with major manufacturers, according to White House officials. The administration paused its plan to enact the duties, originally scheduled
President Donald Trump announced on September 26 that brand-name and patented pharmaceutical products will face a 100% tariff beginning October 1, unless drugmakers are actively constructing manufacturing facilities in the United States. The sweeping tariff policy represents the administration’s most
Amgen has announced a $650 million expansion of its US manufacturing network, creating nearly 750 new jobs at its biologics manufacturing facility in Juncos, Puerto Rico. The investment will support increased drug production and integrate advanced technologies throughout the operations
Novartis has built up substantial pharmaceutical stockpiles in the United States and announced major manufacturing investments as the Swiss company prepares for potential tariffs under President Trump’s trade policies, CEO Vas Narasimhan revealed on Saturday. Speaking to Swiss newspaper Neue
The United States and European Union have finalised details of their trade framework agreement, confirming that pharmaceutical tariffs will be capped at 15% and providing relief to an industry worth €120 billion in annual exports from the EU to the
